3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Stomach Neoplasms
1
Prostatic Neoplasms, Castration-Resistant
1
Ovarian Neoplasms
1
Metastatic Castrate Resistant Prostate Cancer
1
Liver Neoplasms
1
Carcinoma, Renal Cell
1
Interventions
enzalutamide
6
Abiraterone Acetate
4
niraparib
2
Prednisone
2
xentuzumab
1
tasquinimod
1
pembrolizumab
1
darolutamide
1
atezolizumab
1
abiraterone
1
Nivolumab
1
Drug Therapy
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Prostatic Neoplasms, Castration-Resistant
×
tasquinimod
×
Clear all
NCT02057666
2021-04-23
TasQ003
Ipsen
Phase 3
Terminated
146 enrolled
13 charts